Pain Market Research Reports & Industry Analysis
In considering the IASP definition, it is important to note that not all potentially tissue-damaging stimuli result in pain. Nociception is the activation of the primary afferent nerves with peripheral terminals that respond differently to noxious stimuli. Nociceptors function primarily to sense and transmit pain signals. Nociception may or may not be perceived as pain, depending on a complex interaction within the nociceptive pathways. If nociceptive stimuli are blocked, pain is not perceived. Finally, it is important to distinguish pain, or nociception, from suffering. Suffering is the state of severe distress associated with events that threaten the intactness of the person. Suffering is an emotion. Pain and suffering are not the same phenomenon.
The person who complained of pain in the heart because of the death of a loved one is suffering rather than experiencing pain as it is defined by the IASP. It is clear that three conditions could exist: 1) suffering occurs in the presence of pain,2) suffering occurs when pain is not present, and 3) pain occurs when suffering is not present. For example, the woman awaiting breast biopsy may suffer because of anticipated loss of her breast. After the biopsy, she may have pain without suffering if the biopsy is negative or pain with suffering if the biopsy is positive for malignancy. Interventions aimed at relieving pain and suffering may have some commonalities, but clearly some interventions for suffering will be inadequate for pain just as some interventions for pain are inadequate for suffering.
Pain Industry Research & Market Reports
-
Analgesics in Romania
... - including arthritis, injuries, and menstrual discomfort- ibuprofen has shown consistently strong growth. Although the market has gradually moved away from pandemic-induced spikes in demand, the versatile applications of ibuprofen, combined with its widespread accessibility, ... Read More
-
Pain Management Devices Market by Type (Neurostimulation, Infusion Pump, Ablation), Application (Neuropathic, Musculoskeletal, Cancer pain), Mode of Purchase (Prescription, OTC), By End user (Hospital, Physiotherapy, Home care) - Global Forecast to 2029
... management devices market is projected to reach USD 5,835.8 million by 2029 from USD 3,768.6 million in 2024, at a CAGR of 9.1% during the forecast period. The rapid growth in the geriatric population globally ... Read More
-
Global Musculoskeletal Drugs Market 2024-2028
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Pain Management Devices Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... devices report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global pain management devices by categorising the market based ... Read More
-
Global Acetaminophen-Opioid Combination Market Growth (Status and Outlook) 2024-2030
... moderate to severe pain. The acetaminophen enhances the pain-relieving effects of the opioid, allowing for more effective pain control with potentially lower doses of the opioid. This combination is often prescribed for short-term pain management ... Read More
-
Analgesics in Saudi Arabia
... especially if they have been previously recommended by a pharmacist or doctor. Analgesics continue to be used as a first-line medicine for pain relief, addressing a variety of issues such as muscle aches, headaches, pain ... Read More
-
Analgesics in Egypt
... medicine in Egypt, with many people using them to alleviate both common and chronic pain in their day-to-day lives. There is a wide range of analgesics available in Egypt, from single ingredient to combination options. ... Read More
-
Global Non-Opioid Pain Relief Device Market Growth 2024-2030
... downstream market, the Non-Opioid Pain Relief Device is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Opioids
... of 2.3% over the analysis period 2023-2030. Extended-Release / Long-Acting Opioids, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$18.7 Billion by the end of the ... Read More
-
Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, Sublingual, and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034 Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, ... Read More
-
Women's Health Rehabilitation Products
... 2030, growing at a CAGR of 1.2% over the analysis period 2023-2030. Orthopedic Rehabilitation Products, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$731.9 Million by ... Read More
-
Transdermal Scopolamine
... at a CAGR of 5.3% over the analysis period 2023-2030. The U.S. Market is Estimated at US$133.3 Million While China is Forecast to Grow at 5.0% CAGR The Transdermal Scopolamine market in the U.S. is ... Read More
-
Cold Pain Therapy
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. OTC Products, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.9 Billion by ... Read More
-
Radiofrequency Ablation Devices for Pain Management
... reach US$1.4 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Disposable Products, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
-
Peripheral Nerve Stimulators (PNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Peripheral Nerve Stimulators (PNS) pipeline products with comparative analysis of the products at various stages of development ... Read More
-
Virtual Reality (VR) In Healthcare Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... a CAGR of around 35.1% during 2025-2034. This report on global virtual reality (VR) in healthcare market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The ... Read More
-
Cluster Headache Syndrome Global Market Report 2024 Including: 1) By Type: Episodic; Chronic 2) By Drug Type: Calcium Channel Blockers; Corticosteroids; Sumatriptan; Lithium Carbonate; Ergots; Melatonin; Anti-Seizure; Local Anesthetics 3) By Diagnosis: Neurological Examination; Magnetic Resonance Imaging; Computed Tomography Scan 4) By Route of Administration: Oral; Topical; Intravenous 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores Covering: Pfizer Inc.; Bayer AG; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company
... Computed Tomography Scan4) By Route of Administration: Oral; Topical; Intravenous5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online StoresCovering: Pfizer Inc.; Bayer AG; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company Cluster Headache ... Read More
-
Migraine Drugs Market in Latin America 2024-2028
... report on the migraine drugs market in latin america provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Analgesics in Vietnam
... relief from mild pain caused by headaches, stress-related ailments, and age-related conditions. As the population ages, there is a greater need for analgesics. Players continue to expand their product offerings to cater to the needs ... Read More
-
Global OTC Topical Pain Patches Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... comprehensive overview by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various market segments, ... Read More
-
Opioids Market Report by Product Type (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone), Application (Pain Management, Cough Treatment, Diarrhea Treatment, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores, and Others), and Region 2024-2032
... 2024-2032 The global opioids market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.3 Billion by 2032, exhibiting a growth rate (CAGR) of 2.8% during 2024-2032. ... Read More
-
Pharmacogenomics Market Report by Technology (Polymerase Chain Reaction, Microarray, DNA Sequencing, Mass Spectrometry, Electrophoresis, and Others), Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Psychiatry, Pain Management, and Others), End User (Hospitals and Clinics, Academic and Research Institutes), and Region 2024-2032
... and Research Institutes), and Region 2024-2032 The global pharmacogenomics market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.1 Billion by 2032, exhibiting a growth rate ... Read More
-
Topical Pain Relief Market Report by Therapeutic Class (Non-Opioids, Opioids), Formulation (Cream, Gel, Spray, Patch, and Others), Type (Prescription Pain Relief, Over the Counter (OTC) Pain Relief), Distribution Channel (Pharmacy and Drug Stores, Retail Stores, Online Stores), and Region 2024-2032
... Online Stores), and Region 2024-2032 The global topical pain relief market size reached US$ 10.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.1 Billion by 2032, exhibiting a growth ... Read More
-
Global Companion Animal Pharmaceutical Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various market segments, while the ... Read More
Research Assistance
